Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Short term Debt: 2021-2022

Historic Short term Debt for ADC Therapeutics (ADCT) over the last 2 years, with Dec 2022 value amounting to $12.5 million.

  • ADC Therapeutics' Short term Debt rose 89.72% to $12.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was $12.5 million, marking a year-over-year increase of 89.72%. This contributed to the annual value of $12.5 million for FY2022, which is 89.72% up from last year.
  • As of FY2022, ADC Therapeutics' Short term Debt stood at $12.5 million, which was up 89.72% from $6.6 million recorded in FY2021.
  • Over the past 5 years, ADC Therapeutics' Short term Debt peaked at $12.5 million during FY2022, and registered a low of $6.6 million during FY2021.
  • Moreover, its 2-year median value for Short term Debt was $9.5 million (2021), whereas its average is $9.5 million.
  • Data for ADC Therapeutics' Short term Debt shows a peak YoY skyrocketed of 89.72% (in 2022) over the last 5 years.
  • ADC Therapeutics' Short term Debt (Yearly) stood at $6.6 million in 2021, then surged by 89.72% to $12.5 million in 2022.